42
Participants
Start Date
February 28, 2005
Primary Completion Date
August 31, 2007
Study Completion Date
July 31, 2008
Temodar and O6-Benzylguanine
"O6-BG 120mg/m2 administered intravenously over 1 hr followed by continuous infusion of O6-BG at 30 mg/m2/day for 5 consecutive days. Every 48 hrs repeat dose of 120 mg/m2 over 1 hr administered for total of 3 doses.~Temodar administered orally, in fasting state within 60 minutes of end of 1st 1-hr infusion of O6-BG \& then every 24 hrs during continuous infusion of O6-BG. Temodar administered on day 1 of treatment cycle \& every 24 hrs thereafter for 5 days with treatment cycles repeated every 28 days.~Pts must fast for minimum of 1 hr prior to administration of each dose of Temodar \& continue fasting 2 hrs after administration of each Temodar dose."
Duke University Health System, Durham
Lead Sponsor
Collaborators (2)
Schering-Plough
INDUSTRY
Keryx / AOI Pharmaceuticals, Inc.
INDUSTRY
Duke University
OTHER